Patents Assigned to Nectero Medical, Inc.
  • Patent number: 11331102
    Abstract: Disclosed herein is a method of producing high purity pentagalloyl glucose (PGG), analogues or derivatives thereof, at least 99.9% pure, by washing with dimethyl ether. PGG may be provided in a kit, including a hydrolyzer for dissolving the PGG and a saline solution. Also disclosed herein is a device for delivery of a therapeutic solution to a blood vessel. The device may be a catheter having an upstream balloon and a downstream balloon. The upstream balloon may be expanded to anchor the catheter and occlude antegrade blood flow. The downstream balloon may be expanded to occlude retrograde blood flow, creating a sealed volume within the blood vessel. The downstream balloon may have pores configured to deliver a therapeutic inflation solution into the sealed volume or a portion thereof. The downstream balloon may be expanded by the expansion of a balloon disposed inside the downstream balloon.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: May 17, 2022
    Assignee: Nectero Medical, Inc.
    Inventors: Eric Wells, Kelvin Ning
  • Patent number: 9937255
    Abstract: A coated balloon device for stabilizing a section of a blood vessel in a living subject is disclosed. The coating layer of the coated balloon comprises a phenolic compound having a plurality of phenolic groups connected to form a hydrophobic core with peripheral phenolic hydroxyl groups. The coating layer of the coated balloon may contain a hydrophilic polymer to facilitate the release of the phenolic compound. The balloon in general is made of a compliant polymer for atraumatic contact with the blood vessel. In some embodiments, the coating of the coated balloon device further comprises a hydrophilic undercoat layer between the balloon and the coating layer. In some embodiments, the coated balloon device further comprises a sacrificial top coating that dissolves upon delivery into the section of the blood vessel and comprises a hydrophilic composition including sugar, sugar derivatives, or a combination thereof.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: April 10, 2018
    Assignee: NECTERO MEDICAL, INC.
    Inventors: Matthew F. Ogle, Wenda C. Carlyle, Edward J. Anderson, Kishore Udipi
  • Patent number: 9889279
    Abstract: Devices for the isolation of a selected portion of a vessel are described. In some embodiments, the device has an introducer sheath and a sealing catheter that are movable relative to each other to create an isolated volume with adjustable size and location. The methods for the treatment of vascular aneurysms using the devices are described. The treatment is achieved through the delivery of an effective amount of stabilization agent to an isolated volume that encompass the aneurysm. The device optionally has an aspiration device to improve the effectives of the treatment.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: February 13, 2018
    Assignee: Nectero Medical, Inc.
    Inventors: Matthew F. Ogle, Jason C. Isenburg